Bortezomib Impurity 86 | CAS 7524-50-7 - Request Quote
Bortezomib Impurity 86
| SZ CAT No: | SZ-B004134 |
| CAS No | 7524-50-7 |
| Mol.F. | C10H13NO2 : HCl |
| Mol.Wt. | 179.2 : 36.5 |
| Inv. Status | In Stock |
| Rel. CAS No | 2577-90-4 (free base) |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Bortezomib Impurity 86 is chemically Methyl L-phenylalaninate hydrochloride. Bortezomib Impurity 86 is supplied with detailed characterization data compliant with regulatory guideline. Bortezomib Impurity 86 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Bortezomib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 7524-50-7
Purchase 7524-50-7
Order 7524-50-7
Enquire 7524-50-7
price of 7524-50-7
7524-50-7 Supplier
7524-50-7 Manufacturer
7524-50-7 Exporter
buy high quality Bortezomib Impurity 86
Purchase Bortezomib Impurity 86
Bortezomib Impurity 86 suppliers
Bortezomib Impurity 86 manufacturers
Bortezomib Impurity 86 price
Order Bortezomib Impurity 86
Enquire Bortezomib Impurity 86
Bortezomib Impurity 86 cost
Bortezomib Impurity 86 Supplier
Bortezomib Impurity 86 Distributor
Bortezomib Impurity 86 for Method Validation
Bortezomib Reference Standard
Bortezomib Impurity 86 for ANDA Filing
Bortezomib Impurity 86 for Forced Degradation Studies
Bortezomib Impurity 86 Identification Standards
Bortezomib Impurity 86 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.